Arcus Biosciences Inc (NYSE:RCUS)
$ 15.27 -0.56 (-3.54%) Market Cap: 1.40 Bil Enterprise Value: 417.63 Mil PE Ratio: 0 PB Ratio: 2.47 GF Score: 79/100

Arcus Biosciences Inc at Goldman Sachs Healthcare Conference Transcript

Jun 13, 2023 / 11:00PM GMT
Release Date Price: $20.38 (+1.34%)
Salveen Jaswal Richter
Goldman Sachs Group, Inc., Research Division - VP

Good afternoon, everyone. Thanks so much for joining us. I'm Salveen Richter, I cover the biotechnology sector at Goldman Sachs. Really pleased to have with us the Arcus team. So with us, we have Terry Rosen, CEO; and Dimitry Nuyten, CMO.

Terry J. Rosen
Arcus Biosciences, Inc. - Co-Founder, Chairman & CEO

And in the audience, Jen Jarrett.

Questions & Answers

Salveen Jaswal Richter
Goldman Sachs Group, Inc., Research Division - VP

So maybe to start here, ASCO, you recently presented updated data at ASCO. Maybe walk through kind of the key takeaways from that data set and how we should put that in context of kind of the overall outlook here...

Terry J. Rosen
Arcus Biosciences, Inc. - Co-Founder, Chairman & CEO

No, that's an awesome question. So just reminding everybody, specifically, Salveen is talking about our ARC-7 data set which is looking at the first Fc-silent the anti

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot